Author:
Skowasch Dirk,Klose Hans,Ewert Ralf,Wilkens Heinrike,Richter Manuel,Rosenkranz Stephan,Setzer Gesine,Grünig Ekkehard,Halank Michael
Abstract
Idiopathic pulmonary arterial hypertension (IPAH) is often diagnosed in elderly patients with many comorbidities. Whereas a clear treatment strategy and risk assessment is recommended for patients with rare classical IPAH, monotherapy with phosphodiesterase type 5 inhibitors or endothelin receptor antagonists followed by regular follow-up and individualised therapy should be used for patients with many cardiopulmonary comorbidities. Here, we focus on these patients with IPAH and comorbidities, present a review of the literature with a focus on recently published work and summarise factors that may help to provide guidance for individualised treatment approaches in such patients.
Publisher
European Respiratory Society (ERS)
Subject
Pulmonary and Respiratory Medicine